Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: DRUG: docetaxel|DRUG: thalidomide
Sponsor: Case Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)